ProPhase Labs, Inc. (PRPH)

ProPhase Labs Statistics

Total Valuation

ProPhase Labs has a market cap or net worth of $18.26 million. The enterprise value is $45.63 million.

Market Cap	18.26M
Enterprise Value	45.63M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

ProPhase Labs has 23.87 million shares outstanding. The number of shares has increased by 10.53% in one year.

Current Share Class	23.87M
Shares Outstanding	23.87M
Shares Change (YoY)	+10.53%
Shares Change (QoQ)	+1.01%
Owned by Insiders (%)	13.96%
Owned by Institutions (%)	7.80%
Float	20.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.11
Forward PS	0.15
PB Ratio	0.38
P/TBV Ratio	0.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.73.

Current Ratio	1.47
Quick Ratio	1.12
Debt / Equity	0.73
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.60

Financial Efficiency

Return on equity (ROE) is -58.71% and return on invested capital (ROIC) is -31.33%.

Return on Equity (ROE)	-58.71%
Return on Assets (ROA)	-24.12%
Return on Capital (ROIC)	-31.33%
Revenue Per Employee	$112,858
Profits Per Employee	-$245,628
Employee Count	113
Asset Turnover	0.14
Inventory Turnover	3.74

Taxes

Income Tax	-10.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.69% in the last 52 weeks. The beta is -0.10, so ProPhase Labs's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	-82.69%
50-Day Moving Average	2.04
200-Day Moving Average	3.83
Relative Strength Index (RSI)	18.52
Average Volume (20 Days)	277,278

Short Selling Information

The latest short interest is 154,056, so 0.65% of the outstanding shares have been sold short.

Short Interest	154,056
Short Previous Month	206,120
Short % of Shares Out	0.65%
Short % of Float	0.75%
Short Ratio (days to cover)	7.04

Income Statement

In the last 12 months, ProPhase Labs had revenue of $12.75 million and -$27.76 million in losses. Loss per share was -$1.51.

Revenue	12.75M
Gross Profit	-4.13M
Operating Income	-35.41M
Pretax Income	-32.20M
Net Income	-27.76M
EBITDA	-27.88M
EBIT	-35.41M
Loss Per Share	-$1.51

Balance Sheet

The company has $503,000 in cash and $27.87 million in debt, giving a net cash position of -$27.37 million or -$1.15 per share.

Cash & Cash Equivalents	503,000
Total Debt	27.87M
Net Cash	-27.37M
Net Cash Per Share	-$1.15
Equity (Book Value)	38.13M
Book Value Per Share	2.00
Working Capital	13.54M

Cash Flow

In the last 12 months, operating cash flow was -$14.18 million and capital expenditures -$2.45 million, giving a free cash flow of -$16.63 million.

Operating Cash Flow	-14.18M
Capital Expenditures	-2.45M
Free Cash Flow	-16.63M
FCF Per Share	-$0.70

Margins

Gross margin is -32.38%, with operating and profit margins of -277.69% and -217.64%.

Gross Margin	-32.38%
Operating Margin	-277.69%
Pretax Margin	-298.21%
Profit Margin	-217.64%
EBITDA Margin	-218.61%
EBIT Margin	-277.69%
FCF Margin	-71.30%

Dividends & Yields

ProPhase Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.53%
Shareholder Yield	-10.53%
Earnings Yield	-151.97%
FCF Yield	-91.06%

Analyst Forecast

The average price target for ProPhase Labs is $11.00, which is 1,337.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.00
Price Target Difference	1,337.91%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 23, 1997. It was a forward split with a ratio of 2:1.

Last Split Date	Jan 23, 1997
Split Type	Forward
Split Ratio	2:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1